
The Tegan and Circle K-backed mobile lottery ticket platform developer secured series D capital from investors including the Panasonic-financed Conductive Ventures.
Alexandria Venture Investments was among the participants in a series B round which will support clinical trials for Acrivon's lead oncology drug candidate.
Existing investors Lilly Asia Ventures and SBCVC returned for the multiomics product developer's latest round, in which it raised nearly $100m.
Cybersecurity platform developer SafeBreach and home improvement technology provider Block Renovation each raised $50m or over in corporate-led rounds.
Google and Tencent returned to reinvest in e-commerce and on-demand services group GoTo as it prepares to go public at a valuation of up to $30bn.
The Alphabet and DTCP-backed graph software provider added $65m to its latest round, hiking its overall funding to about $580m.
The Salesforce, Workday and ServiceNow-backed software integration provider raised the sries E financing at a $5.7bn valuation.
Vertex Pharmaceuticals and Illumina Ventures both contributed to a round that increased the genetic therapeutics developer's total funding to over $300m.
SoftBank Vision Fund 2 was among the investors in the Recruit-backed business management platform developer’s latest round, which was closed at a $1.7bn valuation.
The machine learning software producer saw Nvidia and New York Life come back for a round which pushed its valuation to $1.7bn.